Assessing a novel, lab-free, point-of-care test for SARS-CoV-2 (CovidNudge): a diagnostic accuracy study
Detection Principle
NucleicAcid-PCR based
Target
drp1, rdrp2, e-gene, n-gene, n1, n2, and n3
Testing Method Category
RT-PCR
Testing Method
CovidNudge point-of-care real-time RT-PCR platform (DnaNudge, UK)
Testing Method - Additional Info
development and clinical assessment of a highly sensitive and specific rapid point-of-care platform for the detection of SARS-CoV-2, validated in frontline clinical settings during the first peak of the COVID-19 pandemic
Reported Performance
Sensitivity: 94%; Specificity: 100%
Sample Size
386 patients
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements